TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

NCT00664313 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

FED

Sponsor class

Conditions

Multi-drug Resistant Tuberculosis
Extensively Drug Resistant Tuberculosis

Interventions

DRUG: Linezolid
DRUG: Placebo

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]
[object Object]